These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A hemolytic plaque assay for the detection of red blood cells carrying abnormal or mutant hemoglobin. Baig MA; Ansari AA; Malling HV J Immunol Methods; 1982 Nov; 55(1):43-50. PubMed ID: 6759580 [TBL] [Abstract][Full Text] [Related]
43. Detection of muramidase (lysozyme)-secreting leucocytes at the single-cell level by a protein A plaque assay. Smith CI; Hammarström L Scand J Immunol; 1980; 11(1):79-84. PubMed ID: 9537032 [TBL] [Abstract][Full Text] [Related]
44. The effect of anti-Ia antibody on immunoglobulin-secreting cells from healthy individuals and myeloma patients. Nagai K; Nagai T; Takatsuki K; Uchino H Scand J Immunol; 1982 Jun; 15(6):567-71. PubMed ID: 6750770 [TBL] [Abstract][Full Text] [Related]
46. Hemolytic plaque inhibition: the physical chemical limits on its use as an affinity assay. DeLisi C J Immunol; 1976 Dec; 117(6):2249-57. PubMed ID: 792343 [TBL] [Abstract][Full Text] [Related]
47. Antigen quantitation by a reverse hemolytic assay. Molinaro GA; Eby WC; Molinaro CA Methods Enzymol; 1981; 73(Pt B):319-26. PubMed ID: 7029203 [No Abstract] [Full Text] [Related]
48. Spontaneous reverse haemolytic plaque formation. I. Technical aspects of the protein A assay. Burns GF; Pike BL J Immunol Methods; 1981; 41(3):269-77. PubMed ID: 7014721 [No Abstract] [Full Text] [Related]
50. Isolation of cells secreting specific polypeptides. Feldman MA; Chou JY In Vitro; 1983 Mar; 19(3 Pt 1):171-4. PubMed ID: 6187664 [TBL] [Abstract][Full Text] [Related]
51. A hemolytic plate method for alternative-pathway complement activity assay. Fong JS; Renaud L Am J Clin Pathol; 1978 Feb; 69(2):156-60. PubMed ID: 343570 [TBL] [Abstract][Full Text] [Related]
52. A simple, rapid, reliable reverse haemolytic plaque assay and positive quality control test for routine use. Hall H; Horsburgh T; Veitch P; Sidgwick A; Bell P J Immunol Methods; 1985 Jun; 80(1):125-35. PubMed ID: 3891858 [TBL] [Abstract][Full Text] [Related]
53. Special considerations for glycolipids and their purification. Smith DF; Prieto PA Curr Protoc Mol Biol; 2001 May; Chapter 17():Unit17.3. PubMed ID: 18265160 [TBL] [Abstract][Full Text] [Related]
54. The hemolytic plaque assay: theory for finite layers. Goldstein B; Perelson AS Biophys Chem; 1977 Jun; 7(1):15-32. PubMed ID: 328066 [No Abstract] [Full Text] [Related]
55. Identification of the IgG1 Induction Factor (Interleukin 4). Severinson E Front Immunol; 2014; 5():628. PubMed ID: 25538711 [No Abstract] [Full Text] [Related]
56. Exploring naphthyl-carbohydrazides as inhibitors of influenza A viruses. Barman S; You L; Chen R; Codrea V; Kago G; Edupuganti R; Robertus J; Krug RM; Anslyn EV Eur J Med Chem; 2014 Jan; 71():81-90. PubMed ID: 24287556 [TBL] [Abstract][Full Text] [Related]
57. ELISpot for measuring human immune responses to vaccines. Slota M; Lim JB; Dang Y; Disis ML Expert Rev Vaccines; 2011 Mar; 10(3):299-306. PubMed ID: 21434798 [TBL] [Abstract][Full Text] [Related]
58. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Coutinho A; Meo T Immunogenetics; 1978 Dec; 7(1):17-24. PubMed ID: 21302052 [TBL] [Abstract][Full Text] [Related]
59. Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region. Dunnick WA; Collins JT; Shi J; Westfield G; Fontaine C; Hakimpour P; Papavasiliou FN J Exp Med; 2009 Nov; 206(12):2613-23. PubMed ID: 19887393 [TBL] [Abstract][Full Text] [Related]
60. Mercury and silver induce B cell activation and anti-nucleolar autoantibody production in outbred mouse stocks: are environmental factors more important than the susceptibility genes in connection with autoimmunity? Abedi-Valugerdi M Clin Exp Immunol; 2009 Jan; 155(1):117-24. PubMed ID: 19076835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]